Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Gorilla and King Portfolio Candidates -- Ignore unavailable to you. Want to Upgrade?

To: Walkingshadow who wrote (11832)	12/3/1999 4:29:00 AM
From: Seeker of Truth	Read Replies (1) \| Respond to of 54805

Dear Walking, Thanks for your eloquent presentation. As we all know the last 12 months have been sensational for tech stocks. Famous names that everybody knows about such as CSCO,EMC,QCOM,JDSU,SEBL, in addition to less well known ones such as Softbank,VRTS,NTAP,CTSH have all at least doubled,several tripled or much more so. So the biotech stocks that you own have participated to a fair extent. But a friend of mine has owned AMGEN for several years and he hasn't seen any gain exceeding that of the S&P 500. I looked up AMGN and found that the expected earnings for 1999 are 98 cents per share and ditto for 2000 is 1.09 per share. The brokers' consensus for the five year growth rate is 16.2% and those are usually optimistic. For a drug company, 16.2% is fine. For a tech stock it's not sensational at all. MLNM on the contrary has a predicted growth rate of 27%. But the estimated earnings for this year is zero and for next year is four cents a share. Isn't the stock getting ahead of itself? Anyway, you've convinced me that there's more life, aka profits, in this sector than I thought. I see princes but no gorillas. The truth is maybe half way between our positions. Good luck, anyway. I'm not shorting AMGN or MLNM.